A common drug slashes your risk of hospitalisation after Covid by as much as a third. An antidepressant costing just 29p was given to half in a new study, with the other participants getting a placebo. The study took place in Brazil, in South America, and its research has now been published in the Lancet. …Fluvoxamine is branded … Continue reading Common 29p drug ‘cuts Covid hospitalisation risk by a third’ – Birmingham Mail